Previous studies have found significant associations between mitochondrial UCP2 and tumor grade in primary breast cancer and reduced sensitivity of breast cancer cells to therapeutic agents by increasing oxidative stress, and some studies show that UCP2 has a critical role in chemotherapeutic drug resistance in pancreatic ductal adenocarcincoma [21–23]. This evidence concerns the gene UCP2 and neoplasm.